Exelixis
EXEL
#1681
Rank
A$15.57 B
Marketcap
$54.54
Share price
1.74%
Change (1 day)
68.58%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company